ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,008Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 944

$429K Total Retail Price of All Prescriptions

Rank: 294 out of 944

283 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 283 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 283 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,750 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 468 411 1 2
FUROSEMIDE 395 366 2 6
SIMVASTATIN 318 261 3 1
OMEPRAZOLE 285 206 4 4
WARFARIN SODIUM 255 240 5 7
HYDROCODONE-ACETAMINOPHEN 250 220 S3 6 10
LISINOPRIL 236 199 7 3
DONEPEZIL HCL 189 189 8 24
METOPROLOL TARTRATE 187 186 9 8
NAMENDA 176 176 10 37
MIRTAZAPINE 176 169 10 35
AMLODIPINE BESYLATE 174 143 12 5
POTASSIUM CHLORIDE 174 166 12 15
SERTRALINE HCL 160 137 14 23
LOSARTAN POTASSIUM 134 123 15 16
PREDNISONE 132 132 16 32
POLYETHYLENE GLYCOL 3350 132 96 16 41
FLUTICASONE PROPIONATE 107 66 18 40
KLOR-CON M20 104 101 19 71
ATORVASTATIN CALCIUM 101 100 20 13
ZOLPIDEM TARTRATE 93 69 21 25
RANITIDINE HCL 87 70 22 42
SPIRONOLACTONE 86 81 23 44
ALLOPURINOL 85 81 24 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 75 25 29
MORPHINE SULFATE ER 83 80 S2 26 80
CITALOPRAM HBR 82 75 27 19
METFORMIN HCL 80 50 28 12
DIOVAN 79 79 29 38
CARVEDILOL 79 76 29 30
TRAZODONE HCL 77 56 31 45
METOPROLOL SUCCINATE 68 68 32 14
FLUOXETINE HCL 67 54 33 48
BACLOFEN 66 42 34 111
CLOPIDOGREL 66 60 34 36
GABAPENTIN 65 34 36 18
LIDODERM 61 57 37 73
HYDROCHLOROTHIAZIDE 60 56 38 9
CHLORTHALIDONE 59 46 39 119
FENTANYL 58 55 S2 40 57
SPIRIVA 55 46 41 65
TAMSULOSIN HCL 55 41 41 27
OXYBUTYNIN CHLORIDE ER 53 53 43 102
VENLAFAXINE HCL ER 52 41 44 84
DIGOXIN 50 50 45 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.